The number drops
And for those using GLP-1 weight loss medications, combining these insights with structured nutritional, movement, and behavioural support will help drive better outcomes and more sustainable results. Enhanced Community-First Support What sets Weight Watchers apart is the power of real human connection
Weight regain risk during the transition Research consistently shows that approximately two-thirds of patients regain weight when they stop GLP-1 receptor agonist therapy
side-effect profile Considerations For example, amylin-based therapies can cause digestive effects, including nausea and vomiting, particularly during initiation or dose escalation
Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer
(This hormone is naturally found in the gut, helps regulate blood sugar, and tells you when youre full